+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Epilepsy Drug"

From
Epilepsy (Central Nervous System) - Drugs In Development, 2021 - Product Thumbnail Image

Epilepsy (Central Nervous System) - Drugs In Development, 2021

  • Drug Pipelines
  • June 2021
  • 789 Pages
  • Global
From
From
P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Pipeline Review, H2 2019 - Product Thumbnail Image

P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Pipeline Review, H2 2019

  • Drug Pipelines
  • August 2019
  • 50 Pages
  • Global
From
From
From
From
Neuroprotection - Methods, Drugs, Markets and Companies - Product Thumbnail Image

Neuroprotection - Methods, Drugs, Markets and Companies

  • Report
  • November 2021
  • 844 Pages
  • Global
From
From
From
Antiepileptic Drugs Market - Forecast (2022 - 2027) - Product Thumbnail Image

Antiepileptic Drugs Market - Forecast (2022 - 2027)

  • Report
  • January 2022
  • 137 Pages
  • Global
From
The Treatment of Epilepsy. 3rd Edition - Product Thumbnail Image

The Treatment of Epilepsy. 3rd Edition

  • Book
  • July 2009
  • 1116 Pages
Loading Indicator

The Epilepsy Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Epilepsy drugs are used to treat seizures, which are caused by abnormal electrical activity in the brain. These drugs work by either suppressing the abnormal electrical activity or increasing the amount of neurotransmitters in the brain. Commonly used epilepsy drugs include anticonvulsants, benzodiazepines, and barbiturates. Epilepsy drugs are used to treat a wide range of seizure types, including tonic-clonic seizures, absence seizures, and myoclonic seizures. They are also used to treat other neurological disorders, such as bipolar disorder and anxiety. The market for epilepsy drugs is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more